bovnews8h
What’s Causing MannKind Corp (MNKD) Stock’s 48.15% Jump Over the Last Six Months?
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
pulmonaryfibrosisnews3d
MNKD-201, inhaled nintedanib for IPF, found safe in healthy people
MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...
Future Market Insights3d
Dry Powder Inhaler Market to Reach USD 29.95 Billion by 2034, Growing at a 3.70% CAGR
The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...
bovnews3d
MannKind Corp (MNKD) Posted 8.07% Profit Margin Last Year—Can It Hold Up?
On Thursday, MannKind Corp (MNKD) stock saw a modest uptick, ending the day at $7.02 which represents a slight increase of $0.06 or 0.86% from the prior close of $6.96. The stock opened at $6.96 and ...
WBJournal5d
Framingham-based biopharma company announces merger agreement with San Diego firm
Pulmatrix, a Framingham-based biopharma company which trades on the Nasdaq exchange, has announced its intent to merge with ...
Business Insider6d
Gossamer Bio (GOSS) Gets a Buy from Oppenheimer
The company’s shares closed yesterday at $0.86. Argyrides covers the Healthcare sector, focusing on stocks such as MannKind, United Therapeutics, and Regulus. According to TipRanks, Argyrides has an ...